Navigation Links
MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
Date:6/28/2008

t of asthma and chronic obstructive pulmonary disease. Additional information about MAP Pharmaceuticals can be found at http://www.mappharma.com.

Forward-Looking Statements

In addition to statements of historical facts or statements of current conditions, this press release contains forward-looking statements, including with respect to our MAP0004 migraine program. Actual results may differ materially from current expectations based on risks and uncertainties affecting MAP Pharmaceuticals' business, including, without limitation, risks and uncertainties relating to the development, clinical testing and potential commercialization of our product candidates. The reader is cautioned not to unduly rely on the forward-looking statements contained in this press release. MAP Pharmaceuticals expressly disclaims any intent or obligation to update these forward-looking statements, except as required by law. Additional information on potential factors that could affect MAP Pharmaceuticals' results and other risks and uncertainties are detailed in its Quarterly Report on Form 10-Q, filed with the SEC on May 14, 2008, and available at http://edgar.sec.gov.


'/>"/>
SOURCE MAP Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
2. Morria Biopharmaceuticals Plc Announces the Initiation of a Phase II Clinical Multi-dose Study of MRX-4 in Allergic Rhinitis
3. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
4. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
5. Peregrine Pharmaceuticals Awarded Two New U.S. Patents Broadening Its Targeted Anti-Phospholipid Patent Portfolio
6. Trubion Pharmaceuticals Announces Presentation of Positive TRU-015 and SBI-087 Data at the 2008 Annual European Congress of Rheumatology Meeting
7. Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy
8. Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
9. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
10. Vion Pharmaceuticals Announces Presentation of Data of Cloretazine(R) (VNP40101M) in Elderly Patients with High-Risk Myelodysplastic Syndromes at the EHA Annual Meeting
11. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)...  Cepheid (Nasdaq: CPHD ) today announced ... Carba-R, with the addition of two newly emerging ... test also detects and differentiates among the five ... NDM, VIM, IMP-1 and OXA-48. "Carbapenem-resistant ... are a growing and expensive challenge for healthcare ...
(Date:7/29/2015)... PITTSBURGH , July 29, 2015  Mylan ... received regulatory clearance from the European Commission under the ... of Perrigo Company plc (NYSE: PRGO ; TASE).  ... Coury commented, "Today marks yet another important milestone ... and serves as further affirmation of the sound industrial ...
(Date:7/29/2015)... 29, 2015  Efforts to improve working capital efficiency ... firms in North America and ... an effective working capital management will ease the difficulties ... Big pharma companies expect to invest in optimizing working ... http://photos.prnewswire.com/prnh/20150724/241957LOGO Analysis from Frost ...
Breaking Medicine Technology:'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 2Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 3Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 5Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 6Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 7Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 8Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 9Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4
(Date:7/29/2015)... ... 29, 2015 , ... It is unique for a health center to dedicate ... care. One that is very hands on and resident oriented, and one to which ... bringing great passion and energy, as well as a strong commitment to helping seniors ...
(Date:7/29/2015)... ... , ... TransFlip is an all new dynamic transition pack for FCPX, containing ... transitions are easy to apply and modify for any skill-level user. TransFlip includes custom ... styles, kinetic flipping panel animations are just a few clicks away. , TransFlip contains ...
(Date:7/29/2015)... , ... July 29, 2015 , ... The New ... project, which will by the end will cost the 501(c) organization nearly $1 million, ... recent anti-ligature requirements. , “We took it down to the studs,” said Geraldine ...
(Date:7/29/2015)... Burnsville MN (PRWEB) , ... July 29, 2015 ... ... manufacturer, announces that it has entered into a partnership with 247Ergo, an ergonomics ... physical health and wellness. Ergonomics projects that the companies undertake could improve worker ...
(Date:7/29/2015)... ... July 29, 2015 , ... Elizabeth Callahan, ... Sarasota to be chosen by the manufacturer to offer and perform Kybella™ ... non-invasive way to treat and eliminate double chin fat,” Dr. Callahan explained. “Previously ...
Breaking Medicine News(10 mins):Health News:New Medical Director Readies To Take Reins at Monarch Landing 2Health News:New Medical Director Readies To Take Reins at Monarch Landing 3Health News:Pixel Film Studios Releases FCPX Transition TransFlip for FCPX 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 2Health News:The New Foundation AZ Renovates Residential Dorms for Youth in Crisis 3Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 2Health News:HealthPostures and 247Ergo Partnership Strengthens America's Wellness 3Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 2Health News:SkinSmart Dermatology is First in Sarasota to Offer Kybella Treatments to Reduce Double Chin Fat 3
... 23 (HealthDay News) -- Swimming may be easy on the ... The most common injury among those who practice the sport ... of competitive swimmers, said Dr. Scott A. Rodeo, co-chief of ... Surgery in New York City, who recently spoke at a ...
... July 22 (HealthDay News) -- Genetic research from Canadian ... An international team of researchers found that some of ... and is found in non-Africans everywhere. Neanderthals are ... in what is now France, Spain, Germany and Russia. ...
... A new study finds that U.S. children with publicly funded ... privately insured. Still, there was good news from ... publicly insured children had a personal doctor and a regular ... cornerstone of health care for children. These results suggest that ...
... study by researchers at Drexel University,s School of Public Health ... gateway to the use of injected drugs such as heroin, ... drugs. The study, published in the International Journal of ... initiation into the misuse of opioid drugs. Common factors identified ...
... FRIDAY, July 22 (HealthDay News) -- As melanoma rates ... 1992, their adoption of American cultural beliefs is associated ... research finds. "Acculturated Latinos might have increased exposure ... expanded social networks, but display decreased engagement in some ...
... FRIDAY, July 22 (HealthDay News) -- With temperatures soaring ... caution when engaging in aerobic activity outdoors or in ... warns. Dr. Cedric X. Bryant, the council,s chief ... heat-related injuries when working out in hot, humid ...
Cached Medicine News:Health News:Common Swimming Injuries Often Avoidable 2Health News:There's a Little Neanderthal in Most of Us 2Health News:Publicly Insured Kids May Get Less Comprehensive Care 2Health News:Drexel study: Misuse of pain medication is pathway to high-risk behaviors 2Health News:Drexel study: Misuse of pain medication is pathway to high-risk behaviors 3Health News:U.S. Culture Linked to Greater Sunscreen Use Among Latinos 2Health News:Extreme Heat Calls for Smarter Workouts 2
... Used for the injection of contrast ... The dual lumen design eliminates the need ... designed to promote atraumatic passage into and ... layer of hydrophilic polymer that when activated, ...
... whistle tip has two staggered eyes. ... the Luer fitting adapter is enclosed. ... of left or right. They are ... x-ray opaque. The length is 65cm ...
Used for directing a flexible tipped wire guide in the ureter. The angled tip allows passage of the catheter past a ureteral stone in preparation for E.S.W.L. Supplied sterile in peel-open packages. ...
... of stainless steel Delta Wire. The revolutionary ... three-prong grasper with the largest possible wire ... Wire creates a grasper with increased radial ... the ureter. Supplied sterile in peel-open packages. ...
Medicine Products: